← Back to headlines

Norway Approves Carvykti Cancer Treatment
Norway's Decision Forum has approved the introduction of Carvykti, a one-time cancer medicine offering up to eight years of improved quality of life for bone marrow cancer patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



